Drug Research
Respiratory Syncytial Virus Jab From Moderna Gets FDA Nod
Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older.
It is well to be noted that...
Drug Research
Meaningful Investment To Enable Tirzepatide API Production
It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon, Indiana, US has gone on to raise the organization’s total investment in the country from...
Drug Research
Germany – Taking Right Steps Towards Pharma Drugs Reshoring
As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened.
The objectives include...
News
CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation
CordenPharma, a global CDMO leader in the manufacture of Drug Substances (APIs) for complex modalities (such as peptides, GalNAc, lipids, etc.), Lipid NanoParticles (LNPs) containing xRNA / xDNA, and injectable Drug Products, and Certest, a Spanish company focused on the...
News
How Dentists Can Make Patients Feel More Comfortable
Visiting the dentist can be a source of anxiety and discomfort for many patients, regardless of their age or the procedure they require. However, creating a welcoming and comfortable environment is crucial for ensuring a positive patient experience and encouraging...
Drug Research
Green Chemistry Innovations Key To Pharma Solvent Sector
The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6 billion mark by 2033 with a CAGR of 4.6% throughout the forecast period.
Let us have...
Drug Research
Inside Out of The Pharmaceutical Fine Chemicals Segment
The pharmaceutical fine chemicals market is all set to showcase significant growth, with an increase from $136 billion in 2024 to an expected $233 billion by 2031. This surge is going to be driven by a CAGR of 8%...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read